These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9002122)

  • 1. Ciprofloxacin in pediatrics: worldwide clinical experience based on compassionate use--safety report.
    Hampel B; Hullmann R; Schmidt H
    Pediatr Infect Dis J; 1997 Jan; 16(1):127-9; discussion 160-2. PubMed ID: 9002122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rheumatologic aspects of pediatric cystic fibrosis patients treated with fluoroquinolones.
    Warren RW
    Pediatr Infect Dis J; 1997 Jan; 16(1):118-22; discussion 123-6. PubMed ID: 9002121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential ciprofloxacin therapy in pediatric cystic fibrosis: comparative study vs. ceftazidime/tobramycin in the treatment of acute pulmonary exacerbations. The Cystic Fibrosis Study Group.
    Church DA; Kanga JF; Kuhn RJ; Rubio TT; Spohn WA; Stevens JC; Painter BG; Thurberg BE; Haverstock DC; Perroncel RY; Echols RM
    Pediatr Infect Dis J; 1997 Jan; 16(1):97-105; discussion 123-6. PubMed ID: 9002118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety profile of quinolone antibiotics in the pediatric population.
    Grady R
    Pediatr Infect Dis J; 2003 Dec; 22(12):1128-32. PubMed ID: 14688586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective analysis of the safety profile of oral and intravenous ciprofloxacin in a geriatric population.
    Heyd A; Haverstock D
    Clin Ther; 2000 Oct; 22(10):1239-50. PubMed ID: 11110234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of ciprofloxacin in paediatric patients--review.
    Kubin R
    Infection; 1993; 21(6):413-21. PubMed ID: 8132376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic disposition of sequential intravenous/oral ciprofloxacin in pediatric cystic fibrosis patients with acute pulmonary exacerbation.
    Rubio TT; Miles MV; Lettieri JT; Kuhn RJ; Echols RM; Church DA
    Pediatr Infect Dis J; 1997 Jan; 16(1):112-7; discussion 123-6. PubMed ID: 9002120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of ciprofloxacin in children: worldwide clinical experience based on compassionate use. Emphasis on joint evaluation.
    Chyský V; Kapila K; Hullmann R; Arcieri G; Schacht P; Echols R
    Infection; 1991; 19(4):289-96. PubMed ID: 1917049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ciprofloxacin as antipseudomonal treatment in patients with cystic fibrosis.
    Schaad UB; Wedgwood J; Ruedeberg A; Kraemer R; Hampel B
    Pediatr Infect Dis J; 1997 Jan; 16(1):106-11; discussion 123-6. PubMed ID: 9002119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ciprofloxacin-induced renal insufficiency in cystic fibrosis.
    Moffett BS; Rosenstein BJ; Mogayzel PJ
    J Cyst Fibros; 2003 Sep; 2(3):152-4. PubMed ID: 15463865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ciprofloxacin safety in a pediatric population.
    Jick S
    Pediatr Infect Dis J; 1997 Jan; 16(1):130-3; discussion 133-4, 160-2. PubMed ID: 9002123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of ciprofloxacin in children with mucoviscidosis].
    Kapranov NI; Kashirskaia NIu; Semykin SIu; Belousov IuB
    Antibiot Khimioter; 1997; 42(6):39-41. PubMed ID: 9313058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The efficacy and safety of ciprofloxacin in treating children with mucoviscidosis].
    Postnikov SS; Semykin SIu; Kapranov NI; Perederko LV; Polikarpova SV
    Antibiot Khimioter; 2000; 45(4):14-7. PubMed ID: 10851644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral ciprofloxacin vs. intravenous ceftazidime plus tobramycin in pediatric cystic fibrosis patients: comparison of antipseudomonas efficacy and assessment of safety with ultrasonography and magnetic resonance imaging. Cystic Fibrosis Study Group.
    Richard DA; Nousia-Arvanitakis S; Sollich V; Hampel BJ; Sommerauer B; Schaad UB
    Pediatr Infect Dis J; 1997 Jun; 16(6):572-8. PubMed ID: 9194107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral ciprofloxacin in the treatment of pseudomonas exacerbations of paediatric cystic fibrosis: clinical efficacy and safety evaluation using magnetic resonance image scanning.
    Redmond A; Sweeney L; MacFarland M; Mitchell M; Daggett S; Kubin R
    J Int Med Res; 1998 Dec; 26(6):304-12. PubMed ID: 10399112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the new quinolones in pediatrics.
    Schaad UB
    Isr J Med Sci; 1994; 30(5-6):463-8. PubMed ID: 8034505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised comparison of ciprofloxacin suspension and pivmecillinam for childhood shigellosis.
    Salam MA; Dhar U; Khan WA; Bennish ML
    Lancet; 1998 Aug; 352(9127):522-7. PubMed ID: 9716056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of the quinolones in paediatrics.
    Schaad UB
    Drugs; 1993; 45 Suppl 3():37-41. PubMed ID: 7689449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Control of a school outbreak of serogroup B meningococcal disease by chemoprophylaxis with azithromycin and ciprofloxacin].
    González de Aledo Linos A; García Merino J
    An Esp Pediatr; 2000 Nov; 53(5):412-7. PubMed ID: 11521657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ciprofloxacin for the treatment of uncomplicated gonorrhea infection in adolescents: does the benefit outweigh the risk?
    Burstein GR; Berman SM; Blumer JL; Moran JS
    Clin Infect Dis; 2002 Oct; 35(Suppl 2):S191-9. PubMed ID: 12353206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.